Progesterone and estrogen receptors in meningiomas: Prognostic considerations

Journal of Neurosurgery

Volumn 86, Issue 1, 1997, Pages 113-120

  Hsu, Dora W ^a   Efird, Jimmy T ^b   Hedley Whyte, E Tessa ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

estrogen receptor; immunocytochemistry; meningioma; mitotic index; progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; CYTOSOL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENINGIOMA; MITOSIS INDEX; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STEROID BINDING;

EID: 0031031277     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.1.0113     Document Type: Article

References (68)

1. Adams EF, Schrell UMH, Fahlbusch R, et al: Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 73:750-755, 1990
2. Al Saati T, Clamens S, Cohen-Knafo E, et al: Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer 55:651-654, 1993
3. Bickerstaff ER, Small JM, Guest IA: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21:89-91, 1958
4. Blaauw G, Blankenstein MA, Lamberts SWJ: Sex steroid receptors in human meningiomas. Acta Neurochir 79:42-47, 1986
5. Blankenstein MA, Berns PMJJ, Blaauw G, et al: Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor. Cancer Res 46:4268s-4270s, 1986
6. Blankenstein MA, Blaauw G, Lamberts SWJ: Progestin and estrogen receptors in human meningioma. Clin Neuropharmacol 7:363-367, 1984
7. Brandis A, Mirzai S, Tatagiba M, et al: Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33:212-218, 1993
8. Cahill DW, Bashirelahi N, Solomon LW, et al: Estrogen and progesterone receptors in meningiomas. J Neurosurg 60: 985-993, 1984
9. Carroll RS, Glowacka D, Dashner K, et al: Progesterone receptor expression in meningiomas. Cancer Res 53:1312-1316. 1993
10. Carroll RS, Zhang J, Dashner K, et al: Androgen receptor expression in meningiomas. J Neurosurg 82:453-460, 1995
11. Christensen D, Laursen H, Klinken L: Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 61:130-134, 1983
12. Clark GM, McGuire WL, Hubay CA, et al: Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 309:1343-1347, 1983
13. Crone KR, Challa VR, Kute TE, et al: Relationship between flow cytometric features and clinical behavior of meningiomas. Neurosurgery 23:720-724, 1988
14. de la Monte SM, Flickinger J, Linggood RM: Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10:836-843, 1986
15. Donnell MS, Meyer GA, Donegan WL: Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50:499-502, 1979
16. Goldberg DE, Stuart J, Koerner FC: Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating. Mod Pathol 7:401-106, 1994
17. Greene GL, Press MF: Immunochemical evaluation of estrogen receptor and progesterone receptor in breast cancer, in Ceriani R (ed): Immunological Approaches to the Diagnosis and Therapy of Breast Cancer. New York: Plenum Publishing, 1987, pp 119-135
18. Grunberg SM, Daniels AM, Muensch H, et al: Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay. J Neurosurg 66:405-108, 1987
19. Grunberg SM, Weiss MH: Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma. J Neurooncol 8:61-65, 1990
20. Grunberg SM, Weiss MH, Spitz IM, et al: Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861-866, 1991
21. Halper J, Colvard DS, Scheithauer BW, et al: Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Neurosurgery 25:546-553, 1989
22. Hayward E, Whitwell H, Paul KS, et al: Steroid receptors in human meningiomas. Clin Neuropharmacol 7:351-356, 1984
23. Hendricks JB, Wilkinson EJ: Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol 6:765-770, 1993
24. Horsfall DJ, Goldsmith KG, Ricciardelli C, et al: Steroid hormone and epidermal growth factor receptors in meningiomas. Aust N Z J Surg 59:881-888, 1989
25. Hoshino T, Nagashima T, Murovic JA, et al: Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 58:1466-1472, 1986
26. Hsu DW, Pardo FS, Efird JT, et al: Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 53:247-255, 1994
27. Ironside JW, Battersby RDE, Dangerfield VJM, et al: Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol 39:44-50, 1986
28. Ironside JW, Battersby RDE, Lawry J, et al: DNA in meningioma tissues and expiant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg 66:588-594, 1987
29. Jääskeläinen J, Haltia M, Laasonen E, et al: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165-172, 1985
30. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986
31. Jääskeläinen J, Laasonen E, Kärkkäinen J, et al: Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases. Acta Neurochir 80:35-41, 1986
32. Jay JR, MacLaughlin DT, Riley KR, et al: Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62:757-762, 1985
33. Jellinger K: Histopathologic features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 7 174, 1988 (Abstract)
34. Khalid H: Immunohistochemical study of estrogen receptor-related antigen, progesteron, and estrogen receptors in human intracranial meningiomas. Cancer 74:679-685, 1994
35. Klijn JGM, de Jong FH, Bakker GH, et al: Antiprogestins, a new form of endocrine therapy for human breast cancer. Cancer Res 49:2851-2856, 1989
36. Lee KS, Hoshino T, Rodriguez LA, et al: Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol 80:311-317, 1990
37. Lesch KP, Engl HG, Gross S: Androgen receptor binding activity in meningiomas. Surg Neurol 28:176-180, 1987
38. Lesch KP, Gross S: Estrogen receptor immunoreactivity in meningiomas. Comparison with the binding activity of estrogen, progesterone and androgen receptors. J Neurosurg 67: 237-243, 1987
39. Maier H, Öfner D, Hittmair A, et al: Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623, 1992
40. Marks SM, Whitwell HL, Lye RH: Recurrence of meningiomas after operation. Surg Neurol 25:436-440, 1986
41. Markwalder TM, Gerber HA, Waelti E, et al: Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Surg Neurol 30:97-101, 1988
42. Markwalder TM, Zava DT, Goldhirsch A, et al: Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol 20:42-47, 1983
43. Martuza RL, Miller DC, MacLaughlin DT: Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. J Neurosurg 62:750-756, 1985
44. Matsuda Y, Kawamoto K, Kiya K, et al: Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80:527-534, 1994
45. Maxwell M, Galanopoulos T, Neville-Golden J, et al: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456-462, 1993
46. May PL, Broome JC, Lawry J, et al: The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71:347-351, 1989
47. Michelsen JJ, New PFJ: Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 32:305-307, 1969
48. Miller RE: Breast cancer and meningioma. J Sure Oncol 31: 182-183, 1986
49. Mirimanoff RO, Dosoretz DE, Linggood RM, et al: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18-24, 1985
50. Olson JJ, Beck DW, MacIndoe JW, et al: Androgen receptors in meningiomas. Cancer 61:952-957, 1988
51. Olson JJ, Beck DW, Schlechte J, et al: Hormonal manipulation of meningiomas in vitro. J Neurosurg 65:99-107, 1986
52. Olson JJ, Beck DW, Schlechte JA, et al: Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66:584-587, 1987
53. Perrot-Applanat M, Groyer-Picard MT, Kujas M: Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 115:20-30, 1992
54. Pichon MF, Pallud C, Brunet M, et al: Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res 40:3357-3360, 1980
55. Press MF, Greene GL: Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology 122:1165-1175, 1988
56. Rausing A, Ybo W, Stenflo J: Intracranial meningioma - a population study of ten years. Acta Neurol Scand 46:102-110, 1970
57. Roggendorf W, Schuster T, Peiffer J: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73:361-364, 1987
58. Rubinstein AB, Loven D, Geier A, et al: Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 81:184-187, 1994
59. Russell DS, Rubenstein LJ: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989, pp 452-453
60. Russell DS, Rubenstein LJ: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1989, p 502
61. Schlegel J, Ullrich B, Stumm G, et al: Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas. Acta Neuropathol 86:473-479, 1993
62. Schnegg JF, Gomez F, LeMarchand-Beraud T, et al: Presence of sex steroid hormone receptors in meningioma tissue. Surg Neurol 15:415-418, 1981
63. Schoenberg BS, Christine BW, Whisnant JP: Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25:705-712, 1975
64. Schrell UMH, Adams EF, Fahlbusch R, et al: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73:743-749, 1990
65. Shibuya M, Hoshino T, Ito S, et al: Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30:494-498, 1992
66. Skullerud K, Löken AC: The prognosis in meningiomas. Acta Neuropathol 29:337-344, 1974
67. Tilzer LL, Plapp FV, Evans JP, et al: Steroid receptor proteins in human meningiomas. Cancer 49:633-636, 1982
68. Whittle IR, Foo MS, Besser M, et al: Progesterone and oestrogen receptors in meningiomas: biochemical and clinicopathological considerations. Aust N Z J Surg 54:325-330, 1984